| 000 | 01197 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514224030.0 | ||
| 264 | 0 | _c20050919 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/j.vaccine.2004.12.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarr, Tom A | |
| 245 | 0 | 0 |
_aCD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens. _h[electronic resource] |
| 260 |
_bVaccine _cMay 2005 |
||
| 300 |
_a3477-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCD40 Antigens _ximmunology |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aCarlring, Jennifer | |
| 700 | 1 | _aHeath, Andrew W | |
| 773 | 0 |
_tVaccine _gvol. 23 _gno. 26 _gp. 3477-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2004.12.025 _zAvailable from publisher's website |
| 999 |
_c15505615 _d15505615 |
||